This article is more than 5 years old. Information may no longer be current.

OSN’s top news of the week

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Here are the top stories of the past week on Healio.com/OSN:

Dexycu receives permanent J-code

Dexycu (dexamethasone intraocular suspension) 9%, the first FDA-approved, single-dose, sustained-release intracameral steroid for the treatment of postoperative inflammation, will have the code J1095. Read more.

Zimura-Lucentis combination safe in wet AMD patients in phase 2a trial

Zimura, a complement factor C5 inhibitor, was found to be well tolerated in combination with Lucentis in a phase 2a clinical trial. Read more.

Mazzo, SEC settle insider trading case

James V. Mazzo, who formerly served as chairman and CEO of Advanced Medical Optics, was charged with sharing nonpublic information regarding that company’s potential acquisition by Abbott Laboratories with a friend, former professional baseball player Douglas V. DeCinces. Read more.

Ocular Bandage Gel shows potential for treating corneal epithelial defects

EyeGate Pharmaceuticals’ Ocular Bandage Gel demonstrated potential for use in treating corneal epithelial defects in a study of patients undergoing photorefractive keratectomy, according to preliminary results. Read more.

Study finds predictors of visual outcomes following vitrectomy for macular hole

Poor preoperative visual acuity, perioperative complications, age-related macular degeneration and delay to surgery are significant predictors of final visual acuity outcomes in patients who underwent small-gauge vitrectomy for full-thickness macular hole, according to a study. Read more.